Neurocrine Biosciences Inc (NASDAQ:NBIX)

43.37
Delayed Data
As of Apr 24
 -0.31 / -0.71%
Today’s Change
12.63
Today|||52-Week Range
45.36
+94.14%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 49.50, with a high estimate of 61.00 and a low estimate of 39.00. The median estimate represents a +14.13% increase from the last price of 43.37.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$0.00
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.73%
 
 
 
 
 
 
Growthannually -23.41%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account